Humacyte $HUMA Study Finds HAV Is Effective Replacement Vessel for CABG Surgery in Baboons
HUMA stock moved 4.6% higher in pre-market trading on January 28, 2022, after the company reported positive animal trial data
Read moreBreaking news on biotech stocks and catalysts which includes FDA announcements, license agreements, and clinical trial data releases.
HUMA stock moved 4.6% higher in pre-market trading on January 28, 2022, after the company reported positive animal trial data
Read moreARDS stock got a bullish commentary from H.C. Wainwright following the revelation that the company received money from the Bill
Read morePFE stock rose in pre-market trading on January 27, 2022, after the company received a positive CHMP opinion for its
Read moreThe penny stock BVXV has exploded more than 16% higher in early trading on January 26, 2022, after Aegis initiated
Read moreCathie Wood’s ARK Investment bought 967K shares of Ginkgo Bioworks on January 25, 2022. Ginkgo Bioworks Announces Acquisition of Massachusetts
Read moreBullish option flow was detected in JNJ stock on January 25, 2022. Bullish Option Flow Johnson & Johnson Reports Q4
Read more